ANP

0.00%

11.0¢

ANTISENSE THERAPEUTICS LIMITED

Market Cap $73.56M Add to my watchlist

RCE'S BREATHROUGH

Recce Pharmaceutical’s continues to advance their breakthrough anti-resistant antibiotic, R327. RCE is hoping this will be a world first for the treatment of deadly sepsis. NEWS: Recce Pharmaceuticals (ASX:RCE) makes quarterly progress on R327.

Latest Threads

Tag

Subject

ANP

For General Information

16 17 18

07:27

1.0K

249K

07:27

Last post dalts66

1.0K

249K

ANP

Ann: Trading Halt

06:57

14K

06:57

Last post RYNZN

14K

ANP

Chart

92 93 94

15/08/22

5.6K

2.0M

15/08/22

Last post arjay

5.6K

2.0M

ANP

Ann: Long COVID-19 strategic collaboration with US Experts

3 4 5

14/08/22

245

61K

14/08/22

Last post dalts66

245

61K

ANP

Long Covid Winter

11/08/22

2.0K

11/08/22

Last post emtbellie

2.0K

ANP

Atl1102 addresses a world market worth over $230 billion

08/08/22

1.5K

08/08/22

Last post RYNZN

1.5K

ANP

Ann: Investor Presentation

03/08/22

7.1K

03/08/22

Last post arjay

7.1K

See All Discussions

Timeline

Trading Halt
15 Aug 09:28	Share

Investor Presentation
28 Jul 09:45	Share

Quarterly Activities/Appendix 4C Cash Flow Report
27 Jul 16:19	Share

ATL1102 DMD Clinical Trial Application Submitted in Europe
13 Jul 09:24	Share

Proteomics and disease marker identification in DMD Webinar
28 Jun 16:57	Share

ANP to Present at the PPMD Annual Conference 2022
24 Jun 09:30	Share

New Indication for ATL1102 Limb Girdle Muscular Dystrophy R2
20 Jun 09:34	Share

Presentation at 2nd Annual Oligonucleotide for CNS Summit
15 Jun 09:07	Share

Investor Presentation
27 May 09:37	Share

Bonus Options Issue - Letter to Shareholders
29 Apr 16:48	Share

Change of Director's Interest Notice (CG,MD)
29 Apr 16:40	Share

Notification regarding unquoted securities - ANP
28 Apr 11:47	Share

Quarterly Activities/Appendix 4C Cash Flow Report
28 Apr 09:30	Share

Receipt of R&D Tax Incentive Payment
14 Apr 08:46	Share

Proposed issue of securities - ANP
12 Apr 09:28	Share

Prospectus
12 Apr 09:22	Share

Bonus Option Offer
12 Apr 09:20	Share

Plasma protein data supports bone density improvement in DMD
14 Mar 09:19	Share

Poster Presentation at 2022 MDA Conference
01 Mar 12:12	Share

Long COVID-19 strategic collaboration with US Experts
24 Feb 12:54	Share

Half Yearly Report and Accounts
23 Feb 17:36	Share

ANP to present at XIX International Conference on DMD
17 Feb 12:03	Share

Dosing commenced in MCRI collaboration animal study
08 Feb 09:31	Share

Cleansing Notice
28 Jan 09:00	Share

Application for quotation of securities - ANP
28 Jan 08:57	Share

Proposed issue of securities - ANP
27 Jan 16:17	Share

Quarterly Report and Appendix 4C
27 Jan 09:11	Share

Cleansing Notice
24 Dec 12:19	Share

Application for quotation of securities - ANP
24 Dec 12:14	Share

Proposed issue of securities - ANP
23 Dec 16:58	Share

View More

(20min delay) Trade with IG
Last 11.0¢		Change 0.000(0.00%)		Mkt cap ! $73.56M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
1	20000	13.0¢

Sellers (Offers)

Price($)	Vol.	No.
12.0¢	65761	3

View Market Depth

No.	Vol.	Price($)
1	20000	0.130
5	63000	0.120
1	50000	0.110
3	109950	0.105
8	329886	0.100

Price($)	Vol.	No.
0.120	65761	3
0.125	24410	1
0.130	100000	1
0.145	66888	1
0.150	104386	3

Last trade - 16.12pm 15/08/2022 (20 minute delay)

ANP (ASX) Chart

Day chart unavailable